BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2974417)

  • 1. Possible site of bronchodilation due to inhaled procaterol aerosol in asthmatic patients.
    Taguchi O; Hida W; Nogami H; Inoue H; Takishima T
    Eur J Clin Pharmacol; 1988; 34(5):433-7. PubMed ID: 2974417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled procaterol versus salbutamol in bronchial asthma.
    Liippo K; Silvasti M; Tukiainen H
    Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of procaterol and salbutamol in single inhaled doses].
    Crespo Notario JA; Sobradillo Peña V; Garnacho López E; Ansola Zubiaurre PM; Mazo Echániz J
    Rev Clin Esp; 1989 Apr; 184(6):297-301. PubMed ID: 2526959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of exercise-induced bronchospasm in asthmatic children. Effect of aerosol and oral procaterol hydrochloride.
    Morooka T; Nishima S; Ota S
    J Asthma; 1987; 24(6):335-46. PubMed ID: 2965139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhaled procaterol hydrochloride in children with bronchial asthma, with particular reference to duration of effect.
    Mitsuhashi M; Kimura T; Tateno K; Morikawa A; Kuroume T
    J Asthma; 1985; 22(4):203-7. PubMed ID: 2931421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of procaterol treatment on beta-adrenergic bronchodilation and polymorphonuclear leukocyte responsiveness.
    Busse WW; Sharpe G; Smith A; Arbabian M; Borgen L; Ruoho A
    Am Rev Respir Dis; 1985 Dec; 132(6):1194-8. PubMed ID: 3000233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients.
    Fontana GA; Lavorini F; Chiostri M; Castellani W; Boddi V; Pistolesi M
    J Aerosol Med; 1999; 12(3):177-85. PubMed ID: 10623334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
    Morin D; Milot J; Turcotte H; Boulet LP
    Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of procaterol on arterial blood gas and pulmonary function in asthmatic children].
    Obata T; Masaki T; Iikura Y
    Arerugi; 1990 Dec; 39(12):1590-7. PubMed ID: 2151420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
    Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
    Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
    Mazza JA; Tashkin DP; Reed CE
    Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new bronchodilating agent, procaterol, in preventing exercise-induced asthma.
    Ioli F; Donner CF; Fracchia C; Manini G; Patessio A; Spada EL; Vecchio C
    Int J Clin Pharmacol Res; 1986; 6(5):389-96. PubMed ID: 2946644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of a long-acting sympathomimetic agent, procaterol, for nocturnal asthma.
    Baughman RP; Loudon RG
    Chest; 1988 Feb; 93(2):285-8. PubMed ID: 2962837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does a beta 2-stimulator really facilitate mucociliary transport in the human lungs in vivo? A study with procaterol.
    Isawa T; Teshima T; Hirano T; Anazawa Y; Miki M; Konno K; Motomiya M
    Am Rev Respir Dis; 1990 Mar; 141(3):715-20. PubMed ID: 1968734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximum bronchodilator effect of pirbuterol and procaterol administered as sprays with and without an aerochamber.
    Solé D; Villalba SR; Sestelo MR; Scalabrin DM; Soares FJ; Naspitz CK
    Rev Paul Med; 1993; 111(3):397-402. PubMed ID: 8108632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in pulmonary function and cross-sectional area of trachea and bronchi in asthmatics following inhalation of procaterol hydrochloride and ipratropium bromide.
    Hoffstein V; Zamel N; McClean P; Chapman KR
    Am J Respir Crit Care Med; 1994 Jan; 149(1):81-5. PubMed ID: 8111604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New assessment of airway responsiveness. Effect of pretreatment with procaterol on allergen-induced bronchoconstriction.
    Takishima T; Taguchi O; Hida W; Nogami H; Shimizu Y; Inoue H
    Chest; 1989 Sep; 96(3):522-7. PubMed ID: 2527732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procaterol metered aerosol in patients with chronic obstructive pulmonary disease.
    Baronti A; Lelli M; Manini G; Verdiani P
    Int J Clin Pharmacol Res; 1987; 7(5):363-8. PubMed ID: 2889678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma.
    Siegel SC; Katz RM; Rachelefsky GS; Brandon ML; Borgen LA
    J Allergy Clin Immunol; 1985 Jun; 75(6):698-705. PubMed ID: 2861219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.
    Chetta A; Del Donno M; Maiocchi G; Pisi G; Moretti D; Olivieri D
    Ann Allergy; 1993 Feb; 70(2):171-4. PubMed ID: 8430925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.